Effect of intravenous alpha-1-antitrypsin augmentation therapy on proteinase-3-generated AaVal541 in deficient patients Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021
Effect of high dose alpha-1-antitrypsin infusion on neutrophil-generated fibrinogen fragments in type Z alpha-1-antitrypsin deficient patients Source: Eur Respir J 2004; 24: Suppl. 48, 307s Year: 2004
Oral corticosteroid treatment reduces serum chitotriosidase activity in patients with COPD Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010
Influence of antibiotics on neutrophil functional activity Source: Annual Congress 2007 - New mechanisms in the pathogenesis of asthma and allergy Year: 2007
Serum surfactant protein D (SPD) and response to the combined therapy in patients (pts) with stable COPD Source: Annual Congress 2012 - COPD treatment and varia Year: 2012
Effects of different serum theophylline concentrations on erythropoietin and hematocrit levels in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 422s Year: 2003
Anti-Factor Xa levels correlate with recurrent venous thromboembolism and clinically relevant bleeding in patients receiving low-molecular-weight heparin. Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism Year: 2019
Effect of vitamin D treatment on antimicrobial peptides in asthma patients and healthy controls Source: Annual Congress 2011 - Asthma mechanisms Year: 2011
Changes in eosinophil count and C reactive protein following treatment with mebendazole in patients with Toxocara-associated asthma Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections Year: 2010
Comparison between the administration of unfractionated heparin (UFH) and low molecular weight heparin (LMWH) in the treatment of pulmonary embolism Source: Annual Congress 2007 - Venous thromboembolic disease Year: 2007
Effect of inhaled heparin on lung function and coagulation in healthy volunteers Source: Eur Respir J 2002; 19: 606-610 Year: 2002
Protein C anticoagulant activity in relation to anti-inflammatory and antiapoptotic activities Source: Lung Science Conference 2008 - Lung Injury, Repair and Remodelling Year: 2008
Effects of high dose N-acetylcysteine in COPD patients Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights Year: 2012
Serum vitamin C level in patients with acute pneumonia and in COPD patients before and after therapy Source: Eur Respir J 2006; 28: Suppl. 50, 38s Year: 2006
Observation results of 484 patients that use TNF alfa inhibitor in respect of the risk of tuberculosis Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control Year: 2008
Evaluation of vitamin A, E and C supplement therapy on immunologic profiles of pulmonary tuberculosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 455s Year: 2005
Thromboprophylaxis and the relationship between C-reactive protein and plasma fibrinogen in patients with acute exacerbations of COPD Source: Eur Respir J 2007; 30: Suppl. 51, 555s Year: 2007
The effect of antithrombin III treatment in septic children Source: Eur Respir J 2003; 22: Suppl. 45, 141s Year: 2003
Influence the phosphatidylcholine treatment program on surfactant protein D levels in hypertensive patients with community-acquired pneumonia Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ? Year: 2018
Inhibition of elastinolytic activity in induced sputum from COPD patients and healthy controls by recombinant alpha 1-antitrypsin (rAAT) and a fusion protein, TAPI Source: Eur Respir J 2004; 24: Suppl. 48, 471s Year: 2004